BioCity Announces Initiation of a Phase 2 Trial for SC0062, a Promising ETA Receptor Antagonist for Chronic Kidney Disease
United States Restorative Dentistry Markets Report 2023: New Product Launches by Key Players to Bolster Growth
A $5.3 Billion Market by 2028 Featuring Key Players- Abbott, Boule, EKF Diagnostics, Shenzhen Mindray Bio-Medical, Sysmex, and Nihon Kohden
European Wellness Signs a Multi-Million MOU for MF3 of Switzerland Supplements & Skincare Exclusivity Distribution for China
Azitra, Inc. Announces Closing of Initial Public Offering
America’s Best Wings: Everything You Need to Know
Charcot’s disease: a treatment to slow down the genetic form
Couserans hospital center: as summer approaches, the unions raise the alert
First time at the crèche or at the nanny: how to manage the separation?
Lourdes: A congress around sports and rugby medicine
Yoga is (also) effective in improving running performance
WUXI, China, June 21, 2023 /PRNewswire/ — BioCity Biopharma, a clinical-stage biopharmaceutical company committed to developing novel and highly differentiated, modality-independent therapeutics for cancer and autoimmune...